Clinical Trial Update: Immunogenicity and Safety of Pentaxim in South African Infants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the immunogenicity and safety of the Pentaxim vaccine in South African infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Infections
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Pentaxim

Snippet

Sponsor: Sanofi | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED